Company
Headquarters: South Burlington, VT, United States
CEO: Mr. Michael Lampron
A$153.2 Million
AUD as of July 1, 2024
US$102.0 Million
Company | Market Cap (USD) |
---|---|
GE HealthCare | $35.26 B |
Veeva Systems Inc. | $29.31 B |
Change Healthcare Inc. | $9.03 B |
Pro Medicus Limited | $8.96 B |
Signify Health, Inc. | $8.38 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises worldwide. It operates through two segments, Sale of Software Licenses and Rendering of Professional Services. The Company offers enterprise diagnostic viewing solutions that include eUnity Enterprise Viewer and eUnity Diagnostic Viewer. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation and training, data migration, support, and maintenance services. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Mach7 Technologies Limited has the following listings and related stock indices.
Stock: ASX: M7T wb_incandescent